nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—BCHE—Cisplatin—esophageal cancer	0.424	1	CbGbCtD
Procaine—HTR3A—vagus nerve—esophageal cancer	0.106	0.369	CbGeAlD
Procaine—BCHE—diaphragm—esophageal cancer	0.0917	0.32	CbGeAlD
Procaine—Meningism—Methotrexate—esophageal cancer	0.0135	0.0802	CcSEcCtD
Procaine—Arachnoiditis—Methotrexate—esophageal cancer	0.0128	0.0761	CcSEcCtD
Procaine—HTR3A—digestive system—esophageal cancer	0.012	0.0418	CbGeAlD
Procaine—SCN10A—lung—esophageal cancer	0.0108	0.0377	CbGeAlD
Procaine—HTR3A—lung—esophageal cancer	0.01	0.0349	CbGeAlD
Procaine—BCHE—bronchus—esophageal cancer	0.00862	0.03	CbGeAlD
Procaine—BCHE—smooth muscle tissue—esophageal cancer	0.00843	0.0294	CbGeAlD
Procaine—SLC6A3—lung—esophageal cancer	0.00834	0.0291	CbGeAlD
Procaine—BCHE—trachea—esophageal cancer	0.00774	0.027	CbGeAlD
Procaine—SCN10A—lymph node—esophageal cancer	0.00739	0.0258	CbGeAlD
Procaine—Clomifene—CYP2A6—esophageal cancer	0.00711	0.194	CrCbGaD
Procaine—Clomifene—CYP19A1—esophageal cancer	0.00677	0.185	CrCbGaD
Procaine—BCHE—digestive system—esophageal cancer	0.00666	0.0232	CbGeAlD
Procaine—Probenecid—ABCC2—esophageal cancer	0.0064	0.174	CrCbGaD
Procaine—Aminohippurate—ABCC2—esophageal cancer	0.00631	0.172	CrCbGaD
Procaine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—esophageal cancer	0.00573	0.068	CbGpPWpGaD
Procaine—Sneezing—Capecitabine—esophageal cancer	0.00567	0.0337	CcSEcCtD
Procaine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—esophageal cancer	0.00563	0.0668	CbGpPWpGaD
Procaine—BCHE—lung—esophageal cancer	0.00556	0.0194	CbGeAlD
Procaine—Nephropathy—Methotrexate—esophageal cancer	0.00491	0.0292	CcSEcCtD
Procaine—BCHE—Irinotecan Pathway—ABCC2—esophageal cancer	0.00431	0.0511	CbGpPWpGaD
Procaine—Body temperature increased—Carboplatin—esophageal cancer	0.0041	0.0244	CcSEcCtD
Procaine—Neuropathy—Cisplatin—esophageal cancer	0.004	0.0238	CcSEcCtD
Procaine—BCHE—lymph node—esophageal cancer	0.0038	0.0133	CbGeAlD
Procaine—Eruption—Methotrexate—esophageal cancer	0.0038	0.0226	CcSEcCtD
Procaine—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00343	0.0204	CcSEcCtD
Procaine—Paralysis—Methotrexate—esophageal cancer	0.00336	0.02	CcSEcCtD
Procaine—SLC6A3—Alpha-synuclein signaling—UCHL1—esophageal cancer	0.00331	0.0393	CbGpPWpGaD
Procaine—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00319	0.019	CcSEcCtD
Procaine—SLC6A3—Alpha-synuclein signaling—FKBP1A—esophageal cancer	0.00315	0.0374	CbGpPWpGaD
Procaine—Neuropathy—Capecitabine—esophageal cancer	0.00295	0.0175	CcSEcCtD
Procaine—SLC6A3—Parkinsons Disease Pathway—UCHL1—esophageal cancer	0.00282	0.0334	CbGpPWpGaD
Procaine—Benzocaine—ABCB1—esophageal cancer	0.00278	0.0756	CrCbGaD
Procaine—Apnoea—Methotrexate—esophageal cancer	0.00276	0.0164	CcSEcCtD
Procaine—Clomifene—ABCB1—esophageal cancer	0.00265	0.0722	CrCbGaD
Procaine—Sweating increased—Cisplatin—esophageal cancer	0.0026	0.0155	CcSEcCtD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—esophageal cancer	0.0026	0.0308	CbGpPWpGaD
Procaine—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00252	0.015	CcSEcCtD
Procaine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00242	0.0144	CcSEcCtD
Procaine—Probenecid—ABCB1—esophageal cancer	0.00235	0.0641	CrCbGaD
Procaine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00234	0.0139	CcSEcCtD
Procaine—Aminohippurate—ABCB1—esophageal cancer	0.00232	0.0633	CrCbGaD
Procaine—Bradycardia—Cisplatin—esophageal cancer	0.00218	0.013	CcSEcCtD
Procaine—Cardiac arrest—Capecitabine—esophageal cancer	0.00217	0.0129	CcSEcCtD
Procaine—SLC6A3—Dopaminergic Neurogenesis—SOX2—esophageal cancer	0.00214	0.0254	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.00209	0.0248	CbGpPWpGaD
Procaine—Tinnitus—Cisplatin—esophageal cancer	0.00199	0.0119	CcSEcCtD
Procaine—Sweating increased—Capecitabine—esophageal cancer	0.00192	0.0114	CcSEcCtD
Procaine—HTR3A—Ion channel transport—ATP1B2—esophageal cancer	0.00191	0.0227	CbGpPWpGaD
Procaine—Erythema—Cisplatin—esophageal cancer	0.00186	0.0111	CcSEcCtD
Procaine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.0018	0.0107	CcSEcCtD
Procaine—Vision blurred—Cisplatin—esophageal cancer	0.00176	0.0104	CcSEcCtD
Procaine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00175	0.0104	CcSEcCtD
Procaine—Tremor—Cisplatin—esophageal cancer	0.00174	0.0104	CcSEcCtD
Procaine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00172	0.0102	CcSEcCtD
Procaine—Leukopenia—Cisplatin—esophageal cancer	0.00167	0.00992	CcSEcCtD
Procaine—HTR3A—Ion channel transport—ATP4A—esophageal cancer	0.00166	0.0196	CbGpPWpGaD
Procaine—Convulsion—Cisplatin—esophageal cancer	0.00161	0.0096	CcSEcCtD
Procaine—Bradycardia—Capecitabine—esophageal cancer	0.00161	0.00955	CcSEcCtD
Procaine—Anxiety—Cisplatin—esophageal cancer	0.00158	0.0094	CcSEcCtD
Procaine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00152	0.00904	CcSEcCtD
Procaine—Oedema—Cisplatin—esophageal cancer	0.00152	0.00904	CcSEcCtD
Procaine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00149	0.00885	CcSEcCtD
Procaine—Tachycardia—Cisplatin—esophageal cancer	0.00148	0.00882	CcSEcCtD
Procaine—Tinnitus—Capecitabine—esophageal cancer	0.00147	0.00875	CcSEcCtD
Procaine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00147	0.00874	CcSEcCtD
Procaine—Eosinophilia—Methotrexate—esophageal cancer	0.00145	0.00864	CcSEcCtD
Procaine—Hypotension—Cisplatin—esophageal cancer	0.00142	0.00845	CcSEcCtD
Procaine—Chills—Capecitabine—esophageal cancer	0.00141	0.00842	CcSEcCtD
Procaine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00138	0.00824	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—ALDH3A1—esophageal cancer	0.00138	0.0164	CbGpPWpGaD
Procaine—Erythema—Capecitabine—esophageal cancer	0.00137	0.00817	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.00135	0.016	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—SLC30A7—esophageal cancer	0.00134	0.0159	CbGpPWpGaD
Procaine—Drowsiness—Methotrexate—esophageal cancer	0.00131	0.00778	CcSEcCtD
Procaine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.0013	0.0154	CbGpPWpGaD
Procaine—Vision blurred—Capecitabine—esophageal cancer	0.00129	0.0077	CcSEcCtD
Procaine—Tremor—Capecitabine—esophageal cancer	0.00129	0.00765	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00124	0.0148	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—BLVRB—esophageal cancer	0.00123	0.0146	CbGpPWpGaD
Procaine—Syncope—Capecitabine—esophageal cancer	0.00123	0.00732	CcSEcCtD
Procaine—Leukopenia—Capecitabine—esophageal cancer	0.00123	0.00731	CcSEcCtD
Procaine—Loss of consciousness—Capecitabine—esophageal cancer	0.00121	0.00718	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.0012	0.0143	CbGpPWpGaD
Procaine—Body temperature increased—Cisplatin—esophageal cancer	0.0012	0.00715	CcSEcCtD
Procaine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00119	0.0141	CbGpPWpGaD
Procaine—Hypertension—Capecitabine—esophageal cancer	0.00119	0.00705	CcSEcCtD
Procaine—Arthralgia—Capecitabine—esophageal cancer	0.00117	0.00695	CcSEcCtD
Procaine—Anxiety—Capecitabine—esophageal cancer	0.00116	0.00693	CcSEcCtD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00112	0.0133	CbGpPWpGaD
Procaine—Oedema—Capecitabine—esophageal cancer	0.00112	0.00666	CcSEcCtD
Procaine—Hypersensitivity—Cisplatin—esophageal cancer	0.00112	0.00666	CcSEcCtD
Procaine—Shock—Capecitabine—esophageal cancer	0.0011	0.00656	CcSEcCtD
Procaine—Thrombocytopenia—Capecitabine—esophageal cancer	0.0011	0.00652	CcSEcCtD
Procaine—Tinnitus—Methotrexate—esophageal cancer	0.00109	0.00651	CcSEcCtD
Procaine—Tachycardia—Capecitabine—esophageal cancer	0.00109	0.0065	CcSEcCtD
Procaine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00108	0.00644	CcSEcCtD
Procaine—Chills—Methotrexate—esophageal cancer	0.00105	0.00627	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—PRDX1—esophageal cancer	0.00105	0.0125	CbGpPWpGaD
Procaine—Hypotension—Capecitabine—esophageal cancer	0.00105	0.00623	CcSEcCtD
Procaine—Diarrhoea—Cisplatin—esophageal cancer	0.00104	0.00619	CcSEcCtD
Procaine—Erythema—Methotrexate—esophageal cancer	0.00102	0.00608	CcSEcCtD
Procaine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00102	0.00607	CcSEcCtD
Procaine—Vomiting—Cisplatin—esophageal cancer	0.000966	0.00575	CcSEcCtD
Procaine—Fatigue—Capecitabine—esophageal cancer	0.000966	0.00575	CcSEcCtD
Procaine—Vision blurred—Methotrexate—esophageal cancer	0.000963	0.00573	CcSEcCtD
Procaine—Rash—Cisplatin—esophageal cancer	0.000958	0.0057	CcSEcCtD
Procaine—Dermatitis—Cisplatin—esophageal cancer	0.000957	0.00569	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—SLC39A6—esophageal cancer	0.000935	0.0111	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—SST—esophageal cancer	0.000935	0.0111	CbGpPWpGaD
Procaine—Leukopenia—Methotrexate—esophageal cancer	0.000915	0.00544	CcSEcCtD
Procaine—Nausea—Cisplatin—esophageal cancer	0.000903	0.00537	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—ADH7—esophageal cancer	0.000892	0.0106	CbGpPWpGaD
Procaine—Urticaria—Capecitabine—esophageal cancer	0.00089	0.00529	CcSEcCtD
Procaine—Body temperature increased—Capecitabine—esophageal cancer	0.000886	0.00527	CcSEcCtD
Procaine—Convulsion—Methotrexate—esophageal cancer	0.000885	0.00527	CcSEcCtD
Procaine—SCN10A—Axon guidance—PFN1—esophageal cancer	0.000871	0.0103	CbGpPWpGaD
Procaine—Arthralgia—Methotrexate—esophageal cancer	0.00087	0.00517	CcSEcCtD
Procaine—CHRNA2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000844	0.01	CbGpPWpGaD
Procaine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000834	0.00496	CcSEcCtD
Procaine—Hypersensitivity—Capecitabine—esophageal cancer	0.000825	0.00491	CcSEcCtD
Procaine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000817	0.00486	CcSEcCtD
Procaine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000806	0.0048	CcSEcCtD
Procaine—Pruritus—Capecitabine—esophageal cancer	0.000793	0.00471	CcSEcCtD
Procaine—CHRNA2—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000791	0.00939	CbGpPWpGaD
Procaine—Hypotension—Methotrexate—esophageal cancer	0.000779	0.00464	CcSEcCtD
Procaine—Diarrhoea—Capecitabine—esophageal cancer	0.000767	0.00456	CcSEcCtD
Procaine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00076	0.00452	CcSEcCtD
Procaine—Somnolence—Methotrexate—esophageal cancer	0.000741	0.00441	CcSEcCtD
Procaine—Dizziness—Capecitabine—esophageal cancer	0.000741	0.00441	CcSEcCtD
Procaine—Fatigue—Methotrexate—esophageal cancer	0.000719	0.00428	CcSEcCtD
Procaine—BCHE—Peptide hormone metabolism—GHRL—esophageal cancer	0.000717	0.00851	CbGpPWpGaD
Procaine—Vomiting—Capecitabine—esophageal cancer	0.000712	0.00424	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000707	0.00839	CbGpPWpGaD
Procaine—Rash—Capecitabine—esophageal cancer	0.000706	0.0042	CcSEcCtD
Procaine—Dermatitis—Capecitabine—esophageal cancer	0.000706	0.0042	CcSEcCtD
Procaine—SCN10A—Axon guidance—CFL1—esophageal cancer	0.000705	0.00837	CbGpPWpGaD
Procaine—Nausea—Capecitabine—esophageal cancer	0.000665	0.00396	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000664	0.00789	CbGpPWpGaD
Procaine—Urticaria—Methotrexate—esophageal cancer	0.000663	0.00394	CcSEcCtD
Procaine—Body temperature increased—Methotrexate—esophageal cancer	0.000659	0.00392	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—ABCC2—esophageal cancer	0.000648	0.00769	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—GNG7—esophageal cancer	0.000647	0.00768	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00063	0.00748	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—PFN1—esophageal cancer	0.000621	0.00737	CbGpPWpGaD
Procaine—Hypersensitivity—Methotrexate—esophageal cancer	0.000614	0.00365	CcSEcCtD
Procaine—CHRNA2—Neuronal System—ALDH2—esophageal cancer	0.000606	0.00719	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—NFE2L2—esophageal cancer	0.000603	0.00715	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000601	0.00713	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—ACTB—esophageal cancer	0.0006	0.00712	CbGpPWpGaD
Procaine—Pruritus—Methotrexate—esophageal cancer	0.00059	0.00351	CcSEcCtD
Procaine—SLC6A3—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000589	0.00699	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000576	0.00684	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000576	0.00684	CbGpPWpGaD
Procaine—Diarrhoea—Methotrexate—esophageal cancer	0.000571	0.00339	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000561	0.00666	CbGpPWpGaD
Procaine—Dizziness—Methotrexate—esophageal cancer	0.000552	0.00328	CcSEcCtD
Procaine—SLC6A3—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000539	0.0064	CbGpPWpGaD
Procaine—Vomiting—Methotrexate—esophageal cancer	0.00053	0.00315	CcSEcCtD
Procaine—Rash—Methotrexate—esophageal cancer	0.000526	0.00313	CcSEcCtD
Procaine—Dermatitis—Methotrexate—esophageal cancer	0.000525	0.00313	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—CYP2A6—esophageal cancer	0.000518	0.00615	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CFL1—esophageal cancer	0.000503	0.00598	CbGpPWpGaD
Procaine—Nausea—Methotrexate—esophageal cancer	0.000495	0.00295	CcSEcCtD
Procaine—SCN10A—Developmental Biology—SOX2—esophageal cancer	0.000486	0.00577	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000466	0.00553	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000459	0.00544	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000457	0.00543	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000437	0.00518	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000437	0.00518	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000428	0.00509	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ACTB—esophageal cancer	0.000428	0.00508	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CTNNA1—esophageal cancer	0.000421	0.00499	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—ABL1—esophageal cancer	0.000402	0.00477	CbGpPWpGaD
Procaine—SCN10A—L1CAM interactions—EGFR—esophageal cancer	0.000399	0.00474	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000396	0.0047	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—TGFBR2—esophageal cancer	0.000363	0.00431	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00036	0.00427	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—HMOX1—esophageal cancer	0.000358	0.00425	CbGpPWpGaD
Procaine—BCHE—Neuronal System—GNG7—esophageal cancer	0.000357	0.00424	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—GNG7—esophageal cancer	0.00035	0.00416	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000336	0.00399	CbGpPWpGaD
Procaine—BCHE—Neuronal System—ALDH2—esophageal cancer	0.000334	0.00397	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—ALDH2—esophageal cancer	0.000328	0.0039	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000316	0.00375	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000312	0.00371	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—KDR—esophageal cancer	0.000304	0.00361	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000299	0.00355	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MET—esophageal cancer	0.000298	0.00353	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ABL1—esophageal cancer	0.000287	0.0034	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000286	0.00339	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—SMAD4—esophageal cancer	0.000278	0.00329	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000274	0.00325	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000274	0.00325	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—XBP1—esophageal cancer	0.000265	0.00314	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—SLC30A7—esophageal cancer	0.000254	0.00301	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000243	0.00289	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000241	0.00287	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000232	0.00275	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000228	0.00271	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—ERBB2—esophageal cancer	0.000218	0.00258	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—KDR—esophageal cancer	0.000217	0.00258	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MET—esophageal cancer	0.000213	0.00252	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000212	0.00252	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000208	0.00246	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—NOTCH1—esophageal cancer	0.000205	0.00243	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC52A3—esophageal cancer	0.000189	0.00224	CbGpPWpGaD
Procaine—BCHE—Metabolism—BLVRB—esophageal cancer	0.000189	0.00224	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000188	0.00224	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CREBBP—esophageal cancer	0.000185	0.0022	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000169	0.002	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC10A2—esophageal cancer	0.00016	0.0019	CbGpPWpGaD
Procaine—BCHE—Metabolism—CA1—esophageal cancer	0.00016	0.0019	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ACTB—esophageal cancer	0.000157	0.00187	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ERBB2—esophageal cancer	0.000155	0.00184	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000155	0.00184	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—EGFR—esophageal cancer	0.000151	0.00179	CbGpPWpGaD
Procaine—BCHE—Metabolism—CA2—esophageal cancer	0.000147	0.00174	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000143	0.0017	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—HSPA5—esophageal cancer	0.000142	0.00169	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—CALR—esophageal cancer	0.000138	0.00163	CbGpPWpGaD
Procaine—BCHE—Metabolism—PLCE1—esophageal cancer	0.000136	0.00162	CbGpPWpGaD
Procaine—BCHE—Metabolism—ADH7—esophageal cancer	0.000136	0.00162	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—GHRL—esophageal cancer	0.000135	0.00161	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000135	0.0016	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—FBXW7—esophageal cancer	0.000133	0.00158	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—EP300—esophageal cancer	0.000126	0.0015	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PIK3CA—esophageal cancer	0.000123	0.00146	CbGpPWpGaD
Procaine—BCHE—Metabolism—ADH1B—esophageal cancer	0.00012	0.00142	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000115	0.00136	CbGpPWpGaD
Procaine—BCHE—Metabolism—TYMP—esophageal cancer	0.000114	0.00136	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP26A1—esophageal cancer	0.000111	0.00132	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00011	0.00131	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALOX15—esophageal cancer	0.000108	0.00129	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—EGFR—esophageal cancer	0.000108	0.00128	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTO1—esophageal cancer	0.000103	0.00123	CbGpPWpGaD
Procaine—BCHE—Metabolism—TPI1—esophageal cancer	0.000103	0.00123	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALDOB—esophageal cancer	9.91e-05	0.00118	CbGpPWpGaD
Procaine—BCHE—Metabolism—GAPDH—esophageal cancer	9.53e-05	0.00113	CbGpPWpGaD
Procaine—BCHE—Metabolism—CRABP1—esophageal cancer	9.45e-05	0.00112	CbGpPWpGaD
Procaine—BCHE—Metabolism—GNG7—esophageal cancer	8.99e-05	0.00107	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALDH2—esophageal cancer	8.42e-05	0.001	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTT1—esophageal cancer	8.01e-05	0.000951	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP2A6—esophageal cancer	7.92e-05	0.00094	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.89e-05	0.000936	CbGpPWpGaD
Procaine—BCHE—Metabolism—ENO1—esophageal cancer	7.51e-05	0.000891	CbGpPWpGaD
Procaine—BCHE—Metabolism—PTGS1—esophageal cancer	7.51e-05	0.000891	CbGpPWpGaD
Procaine—BCHE—Metabolism—PSME1—esophageal cancer	7.4e-05	0.000878	CbGpPWpGaD
Procaine—BCHE—Metabolism—PSME2—esophageal cancer	7.4e-05	0.000878	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.36e-05	0.000874	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.46e-05	0.000767	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP1B1—esophageal cancer	6.38e-05	0.000758	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP19A1—esophageal cancer	6e-05	0.000712	CbGpPWpGaD
Procaine—BCHE—Metabolism—HMOX1—esophageal cancer	5.48e-05	0.00065	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.37e-05	0.000638	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCB1—esophageal cancer	5.26e-05	0.000624	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.97e-05	0.000472	CbGpPWpGaD
Procaine—BCHE—Metabolism—CREBBP—esophageal cancer	3.51e-05	0.000417	CbGpPWpGaD
Procaine—BCHE—Metabolism—NOS3—esophageal cancer	3.15e-05	0.000373	CbGpPWpGaD
Procaine—BCHE—Metabolism—PTGS2—esophageal cancer	2.88e-05	0.000341	CbGpPWpGaD
Procaine—BCHE—Metabolism—EP300—esophageal cancer	2.39e-05	0.000284	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3CA—esophageal cancer	1.77e-05	0.00021	CbGpPWpGaD
